Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: July 2014

HINJ Responds to NPR Report on New Jersey’s Biopharma Sector

New Brunswick, NJ, July 31, 2014 The HealthCare Institute of New Jersey (HINJ) has responded as follows to a National Public Radio (NPR) report regarding New Jersey’s biopharmaceutical sector.

*     *     *

Dan Tucker’s story opens by stating that New Jersey “used to be known as ‘the nation’s medicine chest.’”  While the HealthCare Institute of New Jersey (HINJ) acknowledges that there are a number of vacant pharmaceutical facilities in the state, the status of industry real estate alone is not a true barometer of the industry’s strength in New Jersey.

HINJ contends that — with 13 of the world’s top 20 biopharmaceutical companies and 12 of the world’s top 20 medical technology companies maintaining a significant presence in New Jersey, with the state being one of the largest life sciences clusters in the U.S., and with recent expansion and relocation activity in the state — the Garden State remains the “medicine chest of the world.”

In contrast, this story leads the audience to infer a rather bleak picture and outlook for New Jersey’s life sciences community.

In fact, there are a number of signs that point to an energized life sciences community in New Jersey that were not reflected in this story. Continue reading

HINJ’s CEO Appears on ‘NJ Capitol Report’; Discusses State’s Life Sciences Sector

New Brunswick, NJ, July 21, 2014 ― HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas appears with Emmy Award-winning anchors Steve Adubato and Rafael Pi Roman on “New Jersey Capitol Report” to discuss New Jersey’s life sciences sector.

The episode was first broadcast July 19 on NJTV and Channel Thirteen; it also will air until July 23 on FiOS1, WQXR, WHYY and WBGO.

To view the half-hour episode — Paranicas begins at the 17:45-minute mark — click here. Continue reading

Rutgers-New Brunswick Ranks 33rd Among World’s Top Universities, According to Center for World University Rankings; 24th Among U.S. Universities

New Brunswick, NJ, July 17, 2014 — Rutgers University-New Brunswick  has been ranked 33rd among the world’s top 1,000 universities this year by the Center for World University Rankings —marking a dramatic rise in the ranking of the university’s flagship campus.

Rutgers-New Brunswick also ranked 24th among the 229 U.S. universities that the center included in the world’s top 1,000.

This is the third year that the center has published its rankings. Rutgers rose 10 places in the worldwide rankings this year, up from 43rd last year and 72nd in 2012.  It rose six places in the U.S. rankings, from 30th last year and 49th in 2012.  The rankings place Rutgers ahead of nine Big Ten peers, including Penn State, Ohio State and Purdue. Continue reading

NJTC Names James Barrood as New CEO, Succeeding Maxine Ballen

Mount Laurel, NJ, July 16, 2014 — The New Jersey Technology Council (NJTC) has announced that James Barrood will become its Chief Executive Officer as of August 11.

According to NJBIZ’s Andrew Sheldon, Barrood’s resume includes running Fairleigh Dickinson University’s Rothman Institute of Entrepreneurship since 1997, where he had a large role in connecting the area’s entrepreneurial, enterprise and technology community.

The appointment comes with the stepping-down of NJTC’s founder, CEO and President Maxine Ballen, who headed the institute for 18 years.  During Ballen’s tenure, she grew the institution into one of North America’s most successful trade organizations. Continue reading

Rutgers to Host Biopharma, Health Care Innovation Leaders at North American Summit July 21-22

New Brunswick, NJ, July 15, 2014 — Rutgers, The State University of New Jersey will host the influential TTS Global Initiative’s North American Summit on July 21-22 at Rutgers’ Busch Campus in Piscataway, NJ.

The North American Summit is an annual meeting of top biotech VCs, bankers, biopharmaceutical and health care executives, technology-transfer and licensing directors with universities and institutes, biotech CEOs, and other key stakeholders in early-stage biotech and health care.

The event will offer participants the opportunity to network with peers and discuss the key issues, challenges, and opportunities facing all stakeholders in biopharma and health care innovation. Continue reading

Rutgers Cancer Institute: Survival Benefit Lacking in Older Men Treated with Hormone Therapy for Early-Stage Prostate Cancer

New Brunswick, NJ, July 15, 2014 — Research from investigators at Rutgers Cancer Institute of New Jersey shows a popular prostate cancer treatment that disables male hormones known to promote growth of prostate cancer lacks survival benefit for older men with localized disease.

The study, “Fifteen-Year Survival Outcomes Following Primary Androgen Deprivation Therapy for Localized Prostate Cancer,” focuses on this specific treatment (also known as ADT), which for the past 15 years has become a popular alternative to surgery, radiation or conservative management when used as the only therapy.

The work appears in the latest edition of JAMA Internal Medicine. Continue reading

Rutgers’ Human Genetics Institute Lab Expands into Clinical Testing, Earns Federal Certification

New Brunswick, NJ, July 10, 2014RUCDR Infinite Biologics, a unit of Rutgers’ Human Genetics Institute of New Jersey, has taken a major step toward expanding its focus from conducting and supporting genomic research, where it’s become a recognized global leader, to the rapidly growing field of clinical genomics.

RUCDR, which is the world’s largest university-based biorepository, recently earned its initial certification from the federal Clinical Laboratory Improvement Amendments program.  CLIA, as it’s commonly known in health care, is run by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services. Continue reading

HINJ Announces New Board, Steering Committee Leadership; Daiichi Sankyo’s Craig Bleifer Named Board Chair

Craig Bleifer -- Daiichi Sankyo and HINJ Chair

Craig B. Bleifer, Chair, HINJ Board of Trustees

New Brunswick, NJ, July 8, 2014 ― The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees as well as the leadership of its Steering Committee.

Craig B. Bleifer, Vice President, General Counsel and Secretary, Daiichi Sankyo, Inc., has been named Chair of the HINJ Board of Trustees.

Mr. Bleifer succeeds Kevin T. Rigby, U.S. Country Head Public Affairs, Vice President Public Affairs, Novartis Pharmaceuticals Corporation.  Mr. Rigby will continue to serve on the Board. Continue reading

Rutgers Cancer Institute Director Honored for Contributions to Oncology Field

New Brunswick, NJ, July 8, 2014 — Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey has been selected to receive the Melvyn H. Motolinsky Research Foundation Distinguished Service Award in recognition of his accomplishments and leadership in the field of oncology.

Dr. DiPaola who has international expertise as a prostate cancer physician and researcher, was viewed as a “luminary” in being chosen for this year’s honor, which is reserved for those who make a difference in the lives of many through leadership in healthcare, public health, public service or science.   Continue reading

Now, Officially, Rutgers School of Nursing; Consolidation Expected to Enhance Collaboration, Research Opportunities

New Brunswick, NJ, July 8, 2014 — In sheer size, the “new” Rutgers School of Nursing rivals the largest nurse education programs in the country. Its leaders anticipate it also has the expertise, standards of excellence and direction to become a nationwide academic model.

“We have such a rich mix of expertise to educate students, provide community service and conduct research,” says William Holzemer, dean of the school. “We are very excited about our prospects for the future. The consolidation bodes well not just for nursing in New Jersey but beyond.”

On July 1, 2014, Rutgers’ College of Nursing and School of Nursing, which became part of Rutgers Biomedical and Health Sciences in July, 2013, officially combined and began operating as the School of Nursing, with operations in Newark, New Brunswick and Blackwood. The newly consolidated school has 1,850 students and 125 full-time faculty. Continue reading